Symptoms of migraine in the paediatric population by age group

T Eidlitz-Markus1, O Gorali, Y Haimi-Cohen

  • 1Department of Paediatrics E/Ambulatory Day Care, Schneider Children's Medical Centre of Israel, Petah Tiqwa, Israel. eidlitz@post.tau.ac.il

Insights

Most migraine symptoms are not age-specific in children, according to International Headache Society (IHS) criteria. Vomiting is more common in younger children, and a family history is crucial for diagnosing pediatric migraine.

Area of Science:

  • Neurology
  • Paediatrics
  • Headache Medicine

Background:

  • The International Headache Society (IHS) revised criteria for paediatric headache lack age-specific differentiation.
  • Understanding age-related migraine symptom variations in children is crucial for accurate diagnosis and management.

Purpose of the Study:

  • To investigate if specific migraine symptoms are typical for different paediatric age groups.
  • To compare symptom prevalence across various paediatric age cohorts.

Main Methods:

  • Retrospective review of 160 paediatric migraine patients (aged 6-18) diagnosed using IHS criteria (ICHD-II).
  • Patients categorized into three age groups: preschool (< or =6 years), elementary school (>6 to < or =12 years), and secondary school (>12 to < or =18 years).
  • Comparison of symptom and sign frequency, including migraine with and without aura, across age groups.

Main Results:

  • No significant differences found in unilateral headache, phonophobia, photophobia, awakening pain, nausea, or pain worsening with activity across age groups.
  • Dizziness, migraine duration, and aura prevalence increased with age.
  • Vomiting was significantly more frequent in younger children (preschool group).
  • Nausea and longer migraine duration were more common in migraine with aura compared to migraine without aura.

Conclusions:

  • Most migraine symptoms are not age-specific in children, likely due to continuous brain maturation.
  • A familial history of migraine is common across all paediatric age groups and vital for diagnosis, especially in younger children.
  • Vomiting can be a key diagnostic indicator for paediatric migraine in younger children with a positive family history.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.